ストックスクリーナーアプリを入手
8.94
3.83%
0.33
前日終値:
$8.61
開ける：
$8.69
24時間の取引高:
521.07K
Relative Volume:
0.93
時価総額：
$561.14M
収益：
当期純損益:
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
1週間 パフォーマンス:
-2.19%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$8.50
$9.80
52週間の値動き範囲:
$8.50
$15.50
Electra Therapeutics, Inc. Common stock Stock (ETRA) Company Profile
Compare ETRA vs VRTX, MRNA, REGN, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ETRA
Electra Therapeutics, Inc. Common stock
|
8.94 | 561.14M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
498.50 | 126.35B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
226.30 | 90.35B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
778.36 | 80.14B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
818.30 | 51.46B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
193.52 | 41.48B | 742.00K | -1.37B | -1.07B | -7.0731 |
Electra Therapeutics, Inc. Common stock Stock (ETRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-10-13 | 開始されました | Cantor Fitzgerald | Overweight |
| 2026-10-13 | 開始されました | Evercore ISI | Outperform |
| 2026-10-13 | 開始されました | Jefferies | Buy |
| 2026-10-13 | 開始されました | TD Cowen | Buy |
Electra Therapeutics, Inc. Common stock (ETRA) 最新ニュース
Two entities report shared voting power over more than 5% of Electra Therapeutics (ETRA). - Stock Titan
An investment manager reports a stake above 5% in Electra Therapeutics (ETRA) after its IPO. - Stock Titan
OrbiMed Advisors Discloses Investment at Electra Therapeutics with 11.0% Stake - TradingView
Two funds bought Electra Therapeutics (ETRA) IPO shares at $15. OrbiMed reports their stake. - Stock Titan
Total common shares outstanding of Electra Therapeutics, Inc. – NASDAQ:ETRA - TradingView
Form 4 Electra Therapeutics For: 23 September By Investing.com - Investing.com Nigeria
ETRA SEC Filings, Sep 18, 2026Electra Therapeutics, Inc. Filing Archive - stocktitan.net
Form 4 Electra Therapeutics For: 23 September By Investing.com - Investing.com South Africa
A $15 IPO brought share purchases and preferred-stock conversions at Electra Therapeutics (ETRA). - Stock Titan
At $15 a share, OrbiMed funds bought Electra Therapeutics (ETRA) stock as preferred shares converted. - Stock Titan
Total common shares outstanding of Electra Therapeutics, Inc. – BOATS:ETRA - TradingView
Electra Therapeutics, Inc. Statistics – NASDAQ:ETRA - TradingView
OrbiMed Discloses Preferred Stock Conversion and Significant IPO Share Acquisitions in Electra Therapeutics - Kalkine Media
[Form 4] Electra Therapeutics, Inc. Insider Trading Activity - Stock Titan
Electra Therapeutics (ETRA) director converts 255K preferred in IPO - Stock Titan
Electra Therapeutics (ETRA) CEO converts preferred stake into 455,484 common shares tied to IPO - Stock Titan
Electra Therapeutics (ETRA) Stock Price, News & Analysis - Stock Titan
[Form 4] Electra Therapeutics, Inc. Insider Trading Activity - stocktitan.net
Electra Therapeutics, Inc. Common stock (ETRA) stock price, news, quote and history - Yahoo Finance Australia
Kinzey Capital Management: Electra Sets Nasdaq IPO Terms - GlobeNewswire Inc.
ETRA SEC Filings, Sep 18, 2026Electra Therapeutics, Inc. Filing Archive - Stock Titan
Electra Therapeutics (ETRA) CFO reveals 612K options running to 2036 - Stock Titan
Electra Therapeutics (ETRA) details 2036 option grants for accounting chief - Stock Titan
Electra Therapeutics (ETRA) director details three long-term option grants - Stock Titan
Parry Graham discloses two stock option holdings at Electra Therapeutics (ETRA) - Stock Titan
[Form 3] Electra Therapeutics, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Electra CEO’s option and preferred stake (ETRA) - Stock Titan
Electra Therapeutics (ETRA) CSO discloses stock options and IPO-convertible preferred shares - Stock Titan
OrbiMed funds’ Electra Therapeutics (ETRA) preferred holdings and a director option detailed - Stock Titan
ETRA SEC FilingsElectra Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Electra Therapeutics (ETRA) pursues IPO as auditor raises going-concern warning - Stock Titan
Latham & Watkins Advises on Electra Therapeutics’ Upsized US$350 Million Initial Public Offering - Latham & Watkins LLP
Electra Therapeutics, Inc. Common stock (ETRA) stock price, news, quote and history - Yahoo Finance UK
Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering - GlobeNewswire
Dear Future Electra Therapeutics Stock Fans, Mark Your Calendars for Sept. 18 - Yahoo Finance
Electra amasses $350M in biotech’s latest big IPO - BioPharma Dive
Electra Therapeutics Files for US IPO - Yahoo Finance
Electra Therapeutics files for IPO to fund immune disease drugs By Investing.com - Investing.com India
Electra Therapeutics files for IPO to fund immune disease drugs - Investing.com
Electra Therapeutics, Inc. Common stock (ETRA) 財務データ
Electra Therapeutics, Inc. Common stock (ETRA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Electra Therapeutics, Inc. Common stock (ETRA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | Director |
Sep 21 '26 |
Buy |
15.00 |
1,333,333 |
19,999,995 |
5,126,891 |
6.10%
5.71%
大文字化:
|
ボリューム (24 時間):